Jooeun Kang

Jooeun Kang

Auto-generated profile, based on publicly available information

Jooeun Kang

Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Cancer Cell
Verified
Journal Article
Closed access
MSMinhong Shen
Minhong Shen
YJYi-Zhou Jiang
Yi-Zhou Jiang
YWYong Wei
Yong Wei
BEBrian Ell
Brian Ell
XSXinlei Sheng
Xinlei Sheng
YKYibin Kang
Yibin Kang

6 July 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
ANAllison E. Norlander
Allison E. Norlander
Mohamed A. SalehMohamed A. Saleh
Mohamed A. Saleh
APArvind K. Pandey
Arvind K. Pandey
HIHana A. Itani
Hana A. Itani
JWJing Wu
Jing Wu
MMMeena Madhur
Meena Madhur
We previously showed that angiotensin II (Ang II) increases T cell production of IL-17A, and that mice deficient in IL-17A have blunted hypertension and attenuated renal and vascular dysfunction. It was recently shown that salt enhances IL-17A production from CD4 + T cells via a serum- and glucocorticoid-regulated kinase 1–dependent (SGK1-dependent) pathway. Thus, we tested the hypothesis that SGK1 signaling in T cells promotes hypertension and contributes to end-organ damage. We show that loss of T cell SGK1 results in a blunted hypertensive response to Ang II infusion by 25 mmHg. Importantly, renal and vascular inflammation is abrogated in these mice compared with control mice. Furthermore, mice lacking T cell SGK1 are protected from Ang II–induced endothelial dysfunction and renal injury. Loss of T cell SGK1 also blunts blood pressure and vascular inflammation in response to deoxycorticosterone acetate–salt (DOCA-salt) hypertension. Finally, we demonstrate that the Na + -K + -2Cl – cotransporter 1 (NKCC1) is upregulated in Th17 cells and is necessary for the salt-induced increase in SGK1 and the IL-23 receptor. These studies demonstrate that T cell SGK1 and NKCC1 may be novel therapeutic targets for the treatment of hypertension and identify a potentially new mechanism by which salt contributes to hypertension.

25 May 2021 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
EDEmily DiBlasi
Emily DiBlasi
JKJooeun Kang
Jooeun Kang
ADAnna R. Docherty
Anna R. Docherty
Suicidal ideation, suicide attempt (SA) and suicide are significantly heritable phenotypes. However, the extent to which these phenotypes share genetic architecture is unclear. This question is of great relevance to determining key risk factors for suicide, and to alleviate the societal burden of suicidal thoughts and behaviors (STBs). To help address the question of heterogeneity, consortia efforts have recently shifted from a focus on suicide within the context of major psychopathology (e.g. major depressive disorder, schizophrenia) to suicide as an independent entity. Recent molecular studies of suicide risk by members of the Psychiatric Genomics Consortium and the International Suicide Genetics Consortium have identified genome-wide significant loci associated with SA and with suicide death, and have examined these phenotypes within and outside of the context of major psychopathology. This review summarizes important insights from epidemiological and biometrical research on suicide, and discusses key empirical findings from molecular genetic examinations of STBs. Polygenic risk scores for these phenotypes have been observed to be associated with case−control status and other risk phenotypes. In addition, estimated shared genetic covariance with other phenotypes suggests specific medical and psychiatric risks beyond major depressive disorder. Broadly, molecular studies suggest a complexity of suicide etiology that cannot simply be accounted for by depression. Discussion of the state of suicide genetics, a growing field, also includes important ethical and clinical implications of studying the genetic risk of suicide.

28 March 2022 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
NKNathan A. Kimbrel
Nathan A. Kimbrel
AAAllison E. Ashley-Koch
Allison E. Ashley-Koch
XQXue J. Qin
Xue J. Qin
JLJennifer H. Lindquist
Jennifer H. Lindquist
MGMelanie E. Garrett
Melanie E. Garrett
JBJean C. Beckham
Jean C. Beckham

29 September 2017 in Circulation Research
Verified
Journal Article
Closed access
PDF file
JKJooeun Kang
Jooeun Kang
SHSamson Hennessy-Strahs
Samson Hennessy-Strahs
PKPawel Kwiatkowski
Pawel Kwiatkowski
CBChristian A. Bermudez
Christian A. Bermudez
MAMichael A. Acker
Michael A. Acker
CBCarlo Bartoli
Carlo Bartoli
Rationale:: The objective of this autopsy study was to determine whether gastrointestinal angiodysplasia develops during continuous-flow left ventricular assist device (LVAD) support. Objective:: LVAD support causes pathologic degradation of von Willebrand factor (vWF) and bleeding from gastrointestinal angiodysplasia at an alarming rate. It has been speculated that LVAD support itself may cause angiodysplasia. The relationship to abnormal vWF metabolism is unknown. We tested the hypothesis that abnormal gastrointestinal vascularity develops during continuous-flow LVAD support. Methods and Results:: Small bowel was obtained from deceased humans, cows, and sheep supported with a continuous-flow LVAD (n=9 LVAD, n=11 control). Transmural sections of jejunum were stained with fluorescein isothiocyanate–conjugated isolectin-B4 for endothelium to demarcate vascular structures and quantify intestinal vascularity. Paired plasma samples were obtained from humans before LVAD implantation and during LVAD support (n=41). vWF multimers and degradation fragments were quantified with agarose and polyacrylamide gel electrophoresis and immunoblotting. Abnormal vascular architecture was observed in the submucosa of the jejunum of human patients, cows, and sheep supported with a continuous-flow LVAD. Intestinal vascularity was significantly higher after LVAD support versus controls (5.2±1.0% versus 2.1±0.4%, P =0.004). LVAD support caused significant degradation of high–molecular-weight vWF multimers (–9±1%, P <0.0001) and accumulation of low–molecular-weight vWF multimers (+40±5%, P <0.0001) and vWF degradation fragments (+53±6%, P <0.0001). Conclusions:: Abnormal intestinal vascular architecture and LVAD-associated vWF degradation were consistent findings in multiple species supported with a continuous-flow LVAD. These are the first direct evidence that LVAD support causes gastrointestinal angiodysplasia. Pathologic vWF metabolism may be a mechanistic link between LVAD support, abnormal angiogenesis, gastrointestinal angiodysplasia, and bleeding.

1 November 2015 in JACC: Heart Failure
Verified
Journal Article
Closed access
CBCarlo Bartoli
Carlo Bartoli
JKJooeun Kang
Jooeun Kang
DRDavid J. Restle
David J. Restle
DZDavid M. Zhang
David M. Zhang
CSCameron Shabahang
Cameron Shabahang
PAPavan Atluri
Pavan Atluri